Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rifang Yang"'
Autor:
Li-Rong Yi, Renjun Peng, Cheng Zhang, Zongchao Zuo, Yuwen Cong, Limei Wang, Fan Bai, Zuyin Yu, Li Zhongtang, Ya-Jun Shan, Rifang Yang, Chao Yang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 103:217-228
Purpose The risk of radiation exposure is considered to have increased in recent years. For convenience and simple administration, development of an effective orally administered radioprotective agent is highly desirable. The steroid 5-androstene-3β
Autor:
Lin Guo, Yue Cong, Xingan Wu, Li Zhongtang, Xiaohui Lin, Jun-Xing Dong, Limei Wang, Yuwen Cong, Rifang Yang, Zuyin Yu
Publikováno v:
Scientific Reports
Consequences of primary dsysmenorrhea (PD) can be severe. Increased prostaglandin production leads to uterine contraction and insufficient blood flow to the endometrium causing ischemia and pain symptoms. Protein tyrosine kinase/phosphatase activitie
Autor:
Li-Rong Yi, Limei Wang, Ya-Jun Shan, Zuyin Yu, Renjun Peng, Guo-Lin Xiong, Jun-Xing Dong, Shuang Xing, Fan Bai, Li Zhongtang, Rifang Yang, Yuwen Cong, Chao Jia
Publikováno v:
Scientific Reports
α-tocopherol succinate (α-TOS), γ-tocotrienol (GT3) and δ-tocotrienol (DT3) have drawn large attention due to their efficacy as radioprotective agents. α-TOS has been shown to act superior to α-tocopherol (α-TOH) in mice by reducing lethality
Publikováno v:
Toxicology Letters. 187:45-51
Soman is an organophosphorus neurotoxin which inhibits the activity of acetylcholinesterase (AChE). The goal of this work was to find out whether antibodies against an organophosphorus hapten could protect mice from soman toxicity. An organophosphoru
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 47:583-590
Iptakalim hydrochloride (N-(1-methylethyl)-1,1,2-trimethyl-propylamine hydrochloride) is a promising antihypertensive drug discovered and developed by Beijing Institute of Pharmacology and Toxicology. Deuterium- and tritium-labelled compounds were de
Publikováno v:
European journal of pharmacology. 720(1-3)
Increasing evidence suggests that the mesolimbic dopamine system plays a critical role in opioid addiction. However, there is currently no standard drug treatment for opioid addiction. Growing preclinical evidence indicates that the dopamine D(3) rec
Publikováno v:
European journal of pharmacology.
Increasing evidence suggests that the mesolimbic dopamine system plays a critical role in opioid addiction. However, there is currently no standard drug treatment for opioid addiction. Growing preclinical evidence indicates that the dopamine D
Autor:
Rifang Yang
Publikováno v:
Synthesis; May2003, Vol. 2003 Issue 6, p0887-0893, 7p
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a371dad2f27299dfefe9960af8d46a7e
http://www.scopus.com/inward/record.url?eid=2-s2.0-0006015664&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0006015664&partnerID=MN8TOARS